Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Teva
Dow
Medtronic
Colorcon
Harvard Business School
Cipla
Accenture

Generated: May 25, 2018

DrugPatentWatch Database Preview

Troleandomycin - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for troleandomycin and what is the scope of troleandomycin freedom to operate?

Troleandomycin
is the generic ingredient in one branded drug marketed by Pfizer and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for troleandomycin.
Summary for troleandomycin
Medical Subject Heading (MeSH) Categories for troleandomycin
Synonyms for troleandomycin
(3R,5R,6S,7R,8R,11R,12S,13R,14S,15S)-12-[(4-O-acetyl-2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)oxy]-14-{[2-O-acetyl-3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-5,7,8,11,13,15-hexamethyl-4,10-dio
(3S,5R,6S,7S,8R,11R,12S,13R,14S,15S)-12-[(4-O-acetyl-2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)oxy]-14-{[2-O-acetyl-3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-5,7,8,11,13,15-hexamethyl-4,10-dio
[(3R,5S,6S,7R,8S,9R,12R,13S,14R,15R)-6-[(2S,3R,4S,6R)-3-acetoxy-4-(dimethylamino)-6-methyl-tetrahydropyran-2-yl]oxy-8-[(2R,4S,5S,6S)-5-acetoxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-5,7,9,12,13,15-hexamethyl-10,16-dioxo-
[(3R,5S,6S,7R,8S,9R,12R,13S,14R,15R)-6-[(2S,3R,4S,6R)-3-acetyloxy-4-(dimethylamino)-6-methyloxan-2-yl]oxy-8-[(2R,4S,5S,6S)-5-acetyloxy-4-methoxy-6-methyloxan-2-yl]oxy-5,7,9,12,13,15-hexamethyl-10,16-dioxo-2,11-dioxaspiro[2.13
[(3R,5S,6S,7R,8S,9R,12R,13S,14S,15R)-6-[(2S,3R,4S,6R)-3-acetyloxy-4-(dimethylamino)-6-methyloxan-2-yl]oxy-8-[(2R,4S,5S,6S)-5-acetyloxy-4-methoxy-6-methyloxan-2-yl]oxy-5,7,9,12,13,15-hexamethyl-10,16-d
[(3R,5S,6S,7R,8S,9R,12R,13S,14S,15R)-6-[(2S,3R,4S,6R)-3-acetyloxy-4-(dimethylamino)-6-methyloxan-2-yl]oxy-8-[(2R,4S,5S,6S)-5-acetyloxy-4-methoxy-6-methyloxan-2-yl]oxy-5,7,9,12,13,15-hexamethyl-10,16-dioxo-2,11-dioxaspiro[2.13
[(3S,5S,6S,7R,8S,9R,12R,13S,14S,15R)-6-[(2S,3R,4S,6R)-3-acetyloxy-4-(dimethylamino)-6-methyloxan-2-yl]oxy-8-[(2R,4S,5S,6S)-5-acetyloxy-4-methoxy-6-methyloxan-2-yl]oxy-5,7,9,12,13,15-hexamethyl-10,16-dioxo-2,11-dioxaspiro[2.13
2751-09-9
AB00513798
AB00513798-02
AC1L2AG5
AC1L483V
AC1NR4SQ
ACETYLOLEANDOMYCIN
AI3-50166
Aovine
BDBM50370258
BPBio1_000145
BRD-K38310698-001-01-9
BSPBio_000131
C12753
C41H67NO14
C4DZ64560D
CA006059
CAS-2751-09-9
CCG-220036
CHEBI:45735
CHEMBL3184460
CHEMBL564085
CTK8G3654
Cyclamycin
D01322
D06IGU
DB13179
DR003585
DSSTox_CID_3721
DSSTox_GSID_23721
DSSTox_RID_77163
DTXSID2023721
EINECS 220-392-9
Evramicina
evramycin
FT-0082364
HMS2089B10
HMS2095G13
ioxo-1,11-dioxaspiro[2.13]hexadecan-14-yl] acetate
J-016795
LMPK04000042
LS-98282
Matromicina
Matromycin T
NCGC00016981-01
NCGC00179654-01
NSC 108166
Oleandocetin
Oleandocetine
Oleandomycin triacetate
Oleandomycin triacetate 100 ng/microL in Acetonitrile
oleandomycin triacetate ester
Oleandomycin triacetyl ester
Oleandomycin, triacetate (ester)
Oleandomycin, triacetyl-
oleandomycintriacetylester
oleomycin
Prestwick_594
Prestwick3_000036
SCHEMBL125070
SCHEMBL125071
T.A.O
T.A.O.
TAO
Tao (TN)
Tao (VAN)
Tekmisin (TN)
Tox21_110723
Treis-Micina
Treolmicina
Triacetyl ester of oleandomycin
Triacetyloleandomycin
Triacetyloleandomycin (JAN)
Triacetyloleandomycinum
Tribiocillina
Triocetin
Triocetin (TN)
Triolan
Troleandomicina
Troleandomicina [INN-Spanish]
troleandomycin (TAO)
Troleandomycin (USP/INN)
Troleandomycin [USAN:INN]
Troleandomycin [USAN:USP:INN:BAN]
Troleandomycine
Troleandomycine [INN-French]
Troleandomycinum
Troleandomycinum [INN-Latin]
UNII-C4DZ64560D
Viamicina
WY 651
Wytrion
ZINC169307271

US Patents and Regulatory Information for troleandomycin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer TAO troleandomycin CAPSULE;ORAL 050336-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer TAO troleandomycin SUSPENSION;ORAL 050332-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Healthtrust
Medtronic
Accenture
US Department of Justice
Colorcon
Moodys
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.